Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase III
Bioniche Life Sciences Inc. (BNC) Announces Submission Of Orphan Drug Designation Application For MCNA In The United States 7/29/2014 8:10:57 AM
Puma Biotechnology (PBYI) Shares Soar On Breast Cancer Drug Results 7/23/2014 8:58:42 AM
Celsion Corporation (CLSN) Shows Off Positive ThermoDox┬« Data In Primary Liver Cancer Patients 7/28/2014 8:15:50 AM
Incyte Corporation (INCY)'s Jakafi Fails to Provide RELIEF In Phase 3 Trial 7/24/2014 1:00:44 PM
Incyte Corporation (INCY) Release: Jakafi® (ruxolitinib) Product Label Expanded To Include Overall Survival Data And Additional Safety And Dosing Information 7/28/2014 8:49:58 AM
TetraPhase Pharmaceuticals Completes Enrollment Of IGNITE 1 Eravacycline Phase 3 Clinical Trial in Complicated Intra-abdominal Infections 7/28/2014 8:44:45 AM
Kidney Dialysis Drug Phase 3 Data Boost Keryx Biopharmaceuticals (KERX)'s Hopes For U.S. Approval 7/25/2014 7:40:22 AM
Amgen (AMGN), Bayer HealthCare (BAY)'s Nexavar Fails Late-Stage Breast Cancer Study 7/25/2014 5:45:10 AM
DermaTools Biotech GmbH Release: Clinical Development Of Wound Healing Drug Dermapro® Progressing On Schedule In Europe 7/25/2014 2:46:52 PM
Pfizer Inc. (PFE) Backs Out of Funding Puma Biotechnology (PBYI) Cancer Drug Trials 7/23/2014 9:12:48 AM
Aerie Pharmaceuticals, Inc. (AERI) Receives Health Canada "No Objection Letter" To Commence Phase 3 Registration Trial Of Rhopressatm In Patients With Glaucoma In Canada 7/24/2014 1:02:16 PM
rEVO Biologics Announces Enrollment Of First Patient In Phase 3 Trial Of Atryn® To Treat Early Onset Preeclampsia (PRESERVE-1) 7/24/2014 11:48:03 AM
Merck & Co., Inc. (MRK) Initiates Phase 3 Study Of Letermovir, An Investigational Antiviral For Prevention Of Cytomegalovirus (CMV) Infection In High-Risk Bone Marrow Transplant Patients 7/24/2014 10:54:55 AM
Bayer HealthCare AG (BAY) Release: Phase 3 Investigational Trial Of Azelaic Acid 15% Foam Meets Both Co-Primary Endpoints In Subjects With Papulopustular Rosacea 7/24/2014 9:57:44 AM
Major Advance In UCB Pipeline: Positive Topline Phase 3 Results For brivaracetam In Epilepsy Patients With Partial-Onset Seizures 7/23/2014 6:57:13 AM
1234567
//-->